 | • レポートコード：QAF27740 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の注射用抗凝固剤市場について種類別（低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、その他）、用途別（VTE、ACS/MI、AF、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・注射用抗凝固剤市場の概要 ・世界の主要地域別注射用抗凝固剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の注射用抗凝固剤市場規模2016-2021：種類別（低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、その他） ・世界の注射用抗凝固剤市場予測2012-2027：種類別（低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、その他） ・世界の注射用抗凝固剤市場規模2016-2021：用途別（VTE、ACS/MI、AF、その他） ・世界の注射用抗凝固剤市場予測2012-2027：用途別（VTE、ACS/MI、AF、その他） ・注射用抗凝固剤のアメリカ市場規模と予測2016-2021 ・注射用抗凝固剤のヨーロッパ市場規模と予測2016-2021 ・注射用抗凝固剤の中国市場規模と予測2016-2021 ・注射用抗凝固剤の日本市場規模と予測2016-2021 ・注射用抗凝固剤の東南アジア市場規模と予測2016-2021 ・注射用抗凝固剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka） ・注射用抗凝固剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・注射用抗凝固剤の市場動向・機会・課題 ・調査の結論 |
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
Market Analysis and Insights: Global Injectable Anticoagulants Market
The global Injectable Anticoagulants market was valued at US$ 6158.5 in 2020 and will reach US$ 7268.3 million by the end of 2027, growing at a CAGR of 2.8% during 2022-2027.
Global Injectable Anticoagulants Scope and Market Size
The global Injectable Anticoagulants market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Others
Segment by Application
VTE
ACS/MI
AF
Others
The Injectable Anticoagulants market is analysed and market size information is provided by regions (countries). Segment by Application, the Injectable Anticoagulants market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
1 Injectable Anticoagulants Market Overview
1.1 Injectable Anticoagulants Product Scope
1.2 Injectable Anticoagulants Segment by Type
1.2.1 Global Injectable Anticoagulants Sales by Type (2016 & 2021 & 2027)
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Others
1.3 Injectable Anticoagulants Segment by Application
1.3.1 Global Injectable Anticoagulants Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Injectable Anticoagulants Market Estimates and Forecasts (2016-2027)
1.4.1 Global Injectable Anticoagulants Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Injectable Anticoagulants Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Injectable Anticoagulants Price Trends (2016-2027)
2 Injectable Anticoagulants Estimates and Forecasts by Region
2.1 Global Injectable Anticoagulants Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Injectable Anticoagulants Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Injectable Anticoagulants Sales Market Share by Region (2016-2021)
2.2.2 Global Injectable Anticoagulants Revenue Market Share by Region (2016-2021)
2.3 Global Injectable Anticoagulants Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Injectable Anticoagulants Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Injectable Anticoagulants Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Injectable Anticoagulants Estimates and Projections (2016-2027)
2.4.2 Europe Injectable Anticoagulants Estimates and Projections (2016-2027)
2.4.3 China Injectable Anticoagulants Estimates and Projections (2016-2027)
2.4.4 Japan Injectable Anticoagulants Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Injectable Anticoagulants Estimates and Projections (2016-2027)
2.4.6 India Injectable Anticoagulants Estimates and Projections (2016-2027)
3 Global Injectable Anticoagulants Competition Landscape by Players
3.1 Global Top Injectable Anticoagulants Players by Sales (2016-2021)
3.2 Global Top Injectable Anticoagulants Players by Revenue (2016-2021)
3.3 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2020)
3.4 Global Injectable Anticoagulants Average Price by Company (2016-2021)
3.5 Manufacturers Injectable Anticoagulants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Injectable Anticoagulants Market Size by Type
4.1 Global Injectable Anticoagulants Historic Market Review by Type (2016-2021)
4.1.1 Global Injectable Anticoagulants Sales Market Share by Type (2016-2021)
4.1.2 Global Injectable Anticoagulants Revenue Market Share by Type (2016-2021)
4.1.3 Global Injectable Anticoagulants Price by Type (2016-2021)
4.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Injectable Anticoagulants Sales Forecast by Type (2022-2027)
4.2.2 Global Injectable Anticoagulants Revenue Forecast by Type (2022-2027)
4.2.3 Global Injectable Anticoagulants Price Forecast by Type (2022-2027)
5 Global Injectable Anticoagulants Market Size by Application
5.1 Global Injectable Anticoagulants Historic Market Review by Application (2016-2021)
5.1.1 Global Injectable Anticoagulants Sales Market Share by Application (2016-2021)
5.1.2 Global Injectable Anticoagulants Revenue Market Share by Application (2016-2021)
5.1.3 Global Injectable Anticoagulants Price by Application (2016-2021)
5.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Injectable Anticoagulants Sales Forecast by Application (2022-2027)
5.2.2 Global Injectable Anticoagulants Revenue Forecast by Application (2022-2027)
5.2.3 Global Injectable Anticoagulants Price Forecast by Application (2022-2027)
6 North America Injectable Anticoagulants Market Facts & Figures
6.1 North America Injectable Anticoagulants Sales by Company
6.1.1 North America Injectable Anticoagulants Sales by Company (2016-2021)
6.1.2 North America Injectable Anticoagulants Revenue by Company (2016-2021)
6.2 North America Injectable Anticoagulants Sales Breakdown by Type
6.2.1 North America Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
6.2.2 North America Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
6.3 North America Injectable Anticoagulants Sales Breakdown by Application
6.3.1 North America Injectable Anticoagulants Sales Breakdown by Application (2016-2021)
6.3.2 North America Injectable Anticoagulants Sales Breakdown by Application (2022-2027)
7 Europe Injectable Anticoagulants Market Facts & Figures
7.1 Europe Injectable Anticoagulants Sales by Company
7.1.1 Europe Injectable Anticoagulants Sales by Company (2016-2021)
7.1.2 Europe Injectable Anticoagulants Revenue by Company (2016-2021)
7.2 Europe Injectable Anticoagulants Sales Breakdown by Type
7.2.1 Europe Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
7.2.2 Europe Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
7.3 Europe Injectable Anticoagulants Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Injectable Anticoagulants Market Facts & Figures
8.1 China Injectable Anticoagulants Sales by Company
8.1.1 China Injectable Anticoagulants Sales by Company (2016-2021)
8.1.2 China Injectable Anticoagulants Revenue by Company (2016-2021)
8.2 China Injectable Anticoagulants Sales Breakdown by Type
8.2.1 China Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
8.2.2 China Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
8.3 China Injectable Anticoagulants Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan Injectable Anticoagulants Market Facts & Figures
9.1 Japan Injectable Anticoagulants Sales by Company
9.1.1 Japan Injectable Anticoagulants Sales by Company (2016-2021)
9.1.2 Japan Injectable Anticoagulants Revenue by Company (2016-2021)
9.2 Japan Injectable Anticoagulants Sales Breakdown by Type
9.2.1 Japan Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
9.2.2 Japan Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
9.3 Japan Injectable Anticoagulants Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Injectable Anticoagulants Market Facts & Figures
10.1 Southeast Asia Injectable Anticoagulants Sales by Company
10.1.1 Southeast Asia Injectable Anticoagulants Sales by Company (2016-2021)
10.1.2 Southeast Asia Injectable Anticoagulants Revenue by Company (2016-2021)
10.2 Southeast Asia Injectable Anticoagulants Sales Breakdown by Type
10.2.1 Southeast Asia Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Injectable Anticoagulants Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Injectable Anticoagulants Market Facts & Figures
11.1 India Injectable Anticoagulants Sales by Company
11.1.1 India Injectable Anticoagulants Sales by Company (2016-2021)
11.1.2 India Injectable Anticoagulants Revenue by Company (2016-2021)
11.2 India Injectable Anticoagulants Sales Breakdown by Type
11.2.1 India Injectable Anticoagulants Sales Breakdown by Type (2016-2021)
11.2.2 India Injectable Anticoagulants Sales Breakdown by Type (2022-2027)
11.3 India Injectable Anticoagulants Sales Breakdown by Application
11.3.1 India Injectable Anticoagulants Sales Breakdown by Application (2016-2021)
11.3.2 India Injectable Anticoagulants Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Injectable Anticoagulants Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Injectable Anticoagulants Products Offered
12.1.5 Sanofi Recent Development
12.2 Genentech (Roche)
12.2.1 Genentech (Roche) Corporation Information
12.2.2 Genentech (Roche) Business Overview
12.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Genentech (Roche) Injectable Anticoagulants Products Offered
12.2.5 Genentech (Roche) Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Injectable Anticoagulants Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Injectable Anticoagulants Products Offered
12.4.5 Pfizer Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Corporation Information
12.5.2 The Medicines Company Business Overview
12.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.5.4 The Medicines Company Injectable Anticoagulants Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Aspen
12.6.1 Aspen Corporation Information
12.6.2 Aspen Business Overview
12.6.3 Aspen Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aspen Injectable Anticoagulants Products Offered
12.6.5 Aspen Recent Development
12.7 Otsuka
12.7.1 Otsuka Corporation Information
12.7.2 Otsuka Business Overview
12.7.3 Otsuka Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Otsuka Injectable Anticoagulants Products Offered
12.7.5 Otsuka Recent Development
…
13 Injectable Anticoagulants Manufacturing Cost Analysis
13.1 Injectable Anticoagulants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Injectable Anticoagulants
13.4 Injectable Anticoagulants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Injectable Anticoagulants Distributors List
14.3 Injectable Anticoagulants Customers
15 Market Dynamics
15.1 Injectable Anticoagulants Market Trends
15.2 Injectable Anticoagulants Drivers
15.3 Injectable Anticoagulants Market Challenges
15.4 Injectable Anticoagulants Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Injectable Anticoagulants Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Injectable Anticoagulants Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Injectable Anticoagulants Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Injectable Anticoagulants Sales (K Units) by Region (2016-2021)
Table 5. Global Injectable Anticoagulants Sales Market Share by Region (2016-2021)
Table 6. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Injectable Anticoagulants Revenue Share by Region (2016-2021)
Table 8. Global Injectable Anticoagulants Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Injectable Anticoagulants Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Injectable Anticoagulants Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Injectable Anticoagulants Revenue Share Forecast by Region (2022-2027)
Table 12. Global Injectable Anticoagulants Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Injectable Anticoagulants Sales Share by Company (2016-2021)
Table 14. Global Injectable Anticoagulants Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Injectable Anticoagulants Revenue Share by Company (2016-2021)
Table 16. Global Injectable Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2020)
Table 17. Global Injectable Anticoagulants Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Injectable Anticoagulants Manufacturing Sites and Area Served
Table 19. Manufacturers Injectable Anticoagulants Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Injectable Anticoagulants Sales (K Units) by Type (2016-2021)
Table 22. Global Injectable Anticoagulants Sales Share by Type (2016-2021)
Table 23. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Injectable Anticoagulants Price (USD/Unit) by Type (2016-2021)
Table 25. Global Injectable Anticoagulants Sales Share by Type (2022-2027)
Table 26. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Injectable Anticoagulants Revenue Share by Type (2022-2027)
Table 28. Global Injectable Anticoagulants Price (USD/Unit) by Type (2022-2027)
Table 29. Global Injectable Anticoagulants Sales (K Units) by Application (2016-2021)
Table 30. Global Injectable Anticoagulants Sales Share by Application (2016-2021)
Table 31. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Injectable Anticoagulants Price (USD/Unit) by Application (2016-2021)
Table 33. Global Injectable Anticoagulants Sales (K Units) by Application (2022-2027)
Table 34. Global Injectable Anticoagulants Sales Share by Application (2022-2027)
Table 35. Global Injectable Anticoagulants Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Injectable Anticoagulants Revenue Share by Application (2022-2027)
Table 37. Global Injectable Anticoagulants Price (USD/Unit) by Application (2022-2027)
Table 38. North America Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 39. North America Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 40. North America Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 42. North America Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 43. North America Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 44. North America Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 45. North America Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 46. North America Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 47. North America Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 48. North America Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 49. North America Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 50. Europe Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 51. Europe Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 52. Europe Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 54. Europe Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 55. Europe Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 56. Europe Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 57. Europe Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 58. Europe Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 59. Europe Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 60. Europe Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 61. Europe Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 62. China Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 63. China Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 64. China Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 66. China Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 67. China Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 68. China Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 69. China Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 70. China Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 71. China Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 72. China Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 73. China Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 74. Japan Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 75. Japan Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 76. Japan Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 78. Japan Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 79. Japan Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 80. Japan Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 81. Japan Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 82. Japan Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 83. Japan Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 84. Japan Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 85. Japan Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 98. India Injectable Anticoagulants Sales (K Units) by Company (2016-2021)
Table 99. India Injectable Anticoagulants Sales Market Share by Company (2016-2021)
Table 100. India Injectable Anticoagulants Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Injectable Anticoagulants Revenue Market Share by Company (2016-2021)
Table 102. India Injectable Anticoagulants Sales by Type (2016-2021) & (K Units)
Table 103. India Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 104. India Injectable Anticoagulants Sales by Type (2022-2027) & (K Units)
Table 105. India Injectable Anticoagulants Sales Market Share by Type (2022-2027)
Table 106. India Injectable Anticoagulants Sales by Application (2016-2021) & (K Units)
Table 107. India Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 108. India Injectable Anticoagulants Sales by Application (2022-2027) & (K Units)
Table 109. India Injectable Anticoagulants Sales Market Share by Application (2022-2027)
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Sanofi Injectable Anticoagulants Product
Table 114. Sanofi Recent Development
Table 115. Genentech (Roche) Corporation Information
Table 116. Genentech (Roche) Description and Business Overview
Table 117. Genentech (Roche) Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Genentech (Roche) Injectable Anticoagulants Product
Table 119. Genentech (Roche) Recent Development
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Injectable Anticoagulants Product
Table 124. Boehringer Ingelheim Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Pfizer Injectable Anticoagulants Product
Table 129. Pfizer Recent Development
Table 130. The Medicines Company Corporation Information
Table 131. The Medicines Company Description and Business Overview
Table 132. The Medicines Company Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. The Medicines Company Injectable Anticoagulants Product
Table 134. The Medicines Company Recent Development
Table 135. Aspen Corporation Information
Table 136. Aspen Description and Business Overview
Table 137. Aspen Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Aspen Injectable Anticoagulants Product
Table 139. Aspen Recent Development
Table 140. Otsuka Corporation Information
Table 141. Otsuka Description and Business Overview
Table 142. Otsuka Injectable Anticoagulants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Otsuka Injectable Anticoagulants Product
Table 144. Otsuka Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Injectable Anticoagulants Distributors List
Table 148. Injectable Anticoagulants Customers List
Table 149. Injectable Anticoagulants Market Trends
Table 150. Injectable Anticoagulants Market Drivers
Table 151. Injectable Anticoagulants Market Challenges
Table 152. Injectable Anticoagulants Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Anticoagulants Product Picture
Figure 2. Global Injectable Anticoagulants Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Injectable Anticoagulants Sales Market Share by Application in 2021 & 2027
Figure 6. VTE Examples
Figure 7. ACS/MI Examples
Figure 8. AF Examples
Figure 9. Others Examples
Figure 10. Global Injectable Anticoagulants Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Injectable Anticoagulants Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Injectable Anticoagulants Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Injectable Anticoagulants Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Injectable Anticoagulants Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Injectable Anticoagulants Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Injectable Anticoagulants Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Injectable Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Injectable Anticoagulants Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Injectable Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Injectable Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Injectable Anticoagulants Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Injectable Anticoagulants Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Injectable Anticoagulants Players Market Share by Revenue in Injectable Anticoagulants: 2016 & 2020
Figure 29. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Injectable Anticoagulants Revenue Share by Type (2016-2021)
Figure 31. Global Injectable Anticoagulants Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Injectable Anticoagulants Revenue Share by Application (2016-2021)
Figure 33. Global Injectable Anticoagulants Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 35. North America Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 36. Europe Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 37. Europe Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 38. China Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 39. China Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 40. Japan Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 41. Japan Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 42. Southeast Asia Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 43. Southeast Asia Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 44. India Injectable Anticoagulants Sales Market Share by Type in 2020
Figure 45. India Injectable Anticoagulants Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Injectable Anticoagulants
Figure 48. Manufacturing Process Analysis of Injectable Anticoagulants
Figure 49. Injectable Anticoagulants Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
抗凝固剤のグローバル市場2021 Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the anim…- 新規経口抗凝固剤（NOAC）のグローバル市場調査 2019年 The global Novel Oral AntiCoagulants (NOAC) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Novel Oral AntiCoagulants (NOAC) volume and value at global level, regional level and company level. From …
- 抗凝固薬のグローバル市場調査 2019年 The global Anticoagulants Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anticoagulants Drug volume and value at global level, regional level and company level. From a global perspective, this…
- 世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…
- 世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…